Logo image of REP.DE

REPSOL SA (REP.DE) Stock Fundamental Analysis

FRA:REP - Deutsche Boerse Ag - ES0173516115 - Common Stock - Currency: EUR

13.04  +0 (+0.04%)

Fundamental Rating

3

REP gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 61 industry peers in the Oil, Gas & Consumable Fuels industry. REP has a bad profitability rating. Also its financial health evaluation is rather negative. REP has a valuation in line with the averages, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

REP had positive earnings in the past year.
In the past year REP had a positive cash flow from operations.
REP had positive earnings in 4 of the past 5 years.
In the past 5 years REP always reported a positive cash flow from operatings.
REP.DE Yearly Net Income VS EBIT VS OCF VS FCFREP.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B -2B 4B 6B 8B

1.2 Ratios

REP has a Return On Assets of 2.68%. This is in the lower half of the industry: REP underperforms 60.66% of its industry peers.
REP has a worse Return On Equity (6.40%) than 65.57% of its industry peers.
REP has a Return On Invested Capital of 4.54%. This is in the lower half of the industry: REP underperforms 70.49% of its industry peers.
The Average Return On Invested Capital over the past 3 years for REP is below the industry average of 13.70%.
The last Return On Invested Capital (4.54%) for REP is well below the 3 year average (8.89%), which needs to be investigated, but indicates that REP had better years and this may not be a problem.
Industry RankSector Rank
ROA 2.68%
ROE 6.4%
ROIC 4.54%
ROA(3y)4.91%
ROA(5y)2.45%
ROE(3y)11.61%
ROE(5y)5.85%
ROIC(3y)8.89%
ROIC(5y)N/A
REP.DE Yearly ROA, ROE, ROICREP.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10

1.3 Margins

REP has a worse Profit Margin (2.97%) than 73.77% of its industry peers.
REP's Profit Margin has declined in the last couple of years.
REP has a Operating Margin of 5.06%. This is in the lower half of the industry: REP underperforms 77.05% of its industry peers.
REP's Operating Margin has been stable in the last couple of years.
With a Gross Margin value of 24.51%, REP is not doing good in the industry: 78.69% of the companies in the same industry are doing better.
REP's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 5.06%
PM (TTM) 2.97%
GM 24.51%
OM growth 3Y-24.67%
OM growth 5Y-0.14%
PM growth 3Y-15.4%
PM growth 5YN/A
GM growth 3Y-0.26%
GM growth 5Y0.75%
REP.DE Yearly Profit, Operating, Gross MarginsREP.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20 30

3

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so REP is still creating some value.
REP has less shares outstanding than it did 1 year ago.
REP has less shares outstanding than it did 5 years ago.
The debt/assets ratio for REP is higher compared to a year ago.
REP.DE Yearly Shares OutstandingREP.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B
REP.DE Yearly Total Debt VS Total AssetsREP.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B

2.2 Solvency

REP has an Altman-Z score of 1.45. This is a bad value and indicates that REP is not financially healthy and even has some risk of bankruptcy.
REP has a worse Altman-Z score (1.45) than 62.30% of its industry peers.
The Debt to FCF ratio of REP is 51.58, which is on the high side as it means it would take REP, 51.58 years of fcf income to pay off all of its debts.
REP has a worse Debt to FCF ratio (51.58) than 62.30% of its industry peers.
REP has a Debt/Equity ratio of 0.36. This is a healthy value indicating a solid balance between debt and equity.
REP has a better Debt to Equity ratio (0.36) than 63.93% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.36
Debt/FCF 51.58
Altman-Z 1.45
ROIC/WACC0.69
WACC6.59%
REP.DE Yearly LT Debt VS Equity VS FCFREP.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B

2.3 Liquidity

REP has a Current Ratio of 1.36. This is a normal value and indicates that REP is financially healthy and should not expect problems in meeting its short term obligations.
With a Current ratio value of 1.36, REP perfoms like the industry average, outperforming 44.26% of the companies in the same industry.
A Quick Ratio of 0.96 indicates that REP may have some problems paying its short term obligations.
REP has a Quick ratio of 0.96. This is in the lower half of the industry: REP underperforms 70.49% of its industry peers.
Industry RankSector Rank
Current Ratio 1.36
Quick Ratio 0.96
REP.DE Yearly Current Assets VS Current LiabilitesREP.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B 25B

2

3. Growth

3.1 Past

REP shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -37.07%.
Measured over the past years, REP shows a quite strong growth in Earnings Per Share. The EPS has been growing by 18.66% on average per year.
The Revenue has decreased by -4.11% in the past year.
Measured over the past years, REP shows a small growth in Revenue. The Revenue has been growing by 2.98% on average per year.
EPS 1Y (TTM)-37.07%
EPS 3Y18.66%
EPS 5YN/A
EPS Q2Q%-48.54%
Revenue 1Y (TTM)-4.11%
Revenue growth 3Y4.72%
Revenue growth 5Y2.98%
Sales Q2Q%-0.86%

3.2 Future

The Earnings Per Share is expected to grow by 0.42% on average over the next years.
REP is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -0.62% yearly.
EPS Next Y-16.55%
EPS Next 2Y-3.92%
EPS Next 3Y0.36%
EPS Next 5Y0.42%
Revenue Next Year-2.46%
Revenue Next 2Y-2.11%
Revenue Next 3Y-0.62%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
REP.DE Yearly Revenue VS EstimatesREP.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 20B 40B 60B
REP.DE Yearly EPS VS EstimatesREP.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 1 2 3 4

5

4. Valuation

4.1 Price/Earnings Ratio

REP is valuated cheaply with a Price/Earnings ratio of 5.95.
Compared to the rest of the industry, the Price/Earnings ratio of REP indicates a rather cheap valuation: REP is cheaper than 86.89% of the companies listed in the same industry.
REP is valuated cheaply when we compare the Price/Earnings ratio to 27.53, which is the current average of the S&P500 Index.
The Price/Forward Earnings ratio is 5.25, which indicates a rather cheap valuation of REP.
Based on the Price/Forward Earnings ratio, REP is valued cheaper than 91.80% of the companies in the same industry.
REP is valuated cheaply when we compare the Price/Forward Earnings ratio to 36.71, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 5.95
Fwd PE 5.25
REP.DE Price Earnings VS Forward Price EarningsREP.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

78.69% of the companies in the same industry are more expensive than REP, based on the Enterprise Value to EBITDA ratio.
62.30% of the companies in the same industry are cheaper than REP, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 62.89
EV/EBITDA 2.93
REP.DE Per share dataREP.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-3.92%
EPS Next 3Y0.36%

6

5. Dividend

5.1 Amount

REP has a Yearly Dividend Yield of 6.15%, which is a nice return.
REP's Dividend Yield is a higher than the industry average which is at 58.76.
Compared to an average S&P500 Dividend Yield of 2.34, REP pays a better dividend.
Industry RankSector Rank
Dividend Yield 6.15%

5.2 History

On average, the dividend of REP grows each year by 32.62%, which is quite nice.
Dividend Growth(5Y)32.62%
Div Incr Years4
Div Non Decr Years4
REP.DE Yearly Dividends per shareREP.DE Yearly Dividends per shareYearly Dividends per share 2018 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8

5.3 Sustainability

REP pays out 67.98% of its income as dividend. This is not a sustainable payout ratio.
REP's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP67.98%
EPS Next 2Y-3.92%
EPS Next 3Y0.36%
REP.DE Yearly Income VS Free CF VS DividendREP.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B -2B 4B
REP.DE Dividend Payout.REP.DE Dividend Payout, showing the Payout Ratio.REP.DE Dividend Payout.PayoutRetained Earnings

REPSOL SA

FRA:REP (7/22/2025, 7:00:00 PM)

13.04

+0 (+0.04%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)07-07 2025-07-07/bmo
Earnings (Next)10-06 2025-10-06/bmo
Inst Owners23.62%
Inst Owner ChangeN/A
Ins Owners0.13%
Ins Owner ChangeN/A
Market Cap15.09B
Analysts70.63
Price Target13.67 (4.83%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 6.15%
Yearly Dividend0.97
Dividend Growth(5Y)32.62%
DP67.98%
Div Incr Years4
Div Non Decr Years4
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)5.14%
Min EPS beat(2)-7.85%
Max EPS beat(2)18.12%
EPS beat(4)3
Avg EPS beat(4)12.61%
Min EPS beat(4)-7.85%
Max EPS beat(4)22.09%
EPS beat(8)6
Avg EPS beat(8)16.72%
EPS beat(12)9
Avg EPS beat(12)13.85%
EPS beat(16)12
Avg EPS beat(16)13.09%
Revenue beat(2)0
Avg Revenue beat(2)-8.97%
Min Revenue beat(2)-9.59%
Max Revenue beat(2)-8.34%
Revenue beat(4)0
Avg Revenue beat(4)-13.18%
Min Revenue beat(4)-18.76%
Max Revenue beat(4)-8.34%
Revenue beat(8)1
Avg Revenue beat(8)-8.87%
Revenue beat(12)2
Avg Revenue beat(12)-8.61%
Revenue beat(16)3
Avg Revenue beat(16)-9.39%
PT rev (1m)0.91%
PT rev (3m)-7.02%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.74%
Valuation
Industry RankSector Rank
PE 5.95
Fwd PE 5.25
P/S 0.26
P/FCF 62.89
P/OCF 3.04
P/B 0.57
P/tB 0.65
EV/EBITDA 2.93
EPS(TTM)2.19
EY16.79%
EPS(NY)2.48
Fwd EY19.04%
FCF(TTM)0.21
FCFY1.59%
OCF(TTM)4.29
OCFY32.9%
SpS49.35
BVpS22.89
TBVpS20.19
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 2.68%
ROE 6.4%
ROCE 6.08%
ROIC 4.54%
ROICexc 5.31%
ROICexgc 5.75%
OM 5.06%
PM (TTM) 2.97%
GM 24.51%
FCFM 0.42%
ROA(3y)4.91%
ROA(5y)2.45%
ROE(3y)11.61%
ROE(5y)5.85%
ROIC(3y)8.89%
ROIC(5y)N/A
ROICexc(3y)11.29%
ROICexc(5y)N/A
ROICexgc(3y)12.06%
ROICexgc(5y)N/A
ROCE(3y)11.91%
ROCE(5y)N/A
ROICexcg growth 3Y-35.12%
ROICexcg growth 5Y-0.05%
ROICexc growth 3Y-33.47%
ROICexc growth 5Y0.93%
OM growth 3Y-24.67%
OM growth 5Y-0.14%
PM growth 3Y-15.4%
PM growth 5YN/A
GM growth 3Y-0.26%
GM growth 5Y0.75%
F-Score4
Asset Turnover0.9
Health
Industry RankSector Rank
Debt/Equity 0.36
Debt/FCF 51.58
Debt/EBITDA 1.61
Cap/Depr 159.95%
Cap/Sales 8.27%
Interest Coverage 7.2
Cash Conversion 84.97%
Profit Quality 14.15%
Current Ratio 1.36
Quick Ratio 0.96
Altman-Z 1.45
F-Score4
WACC6.59%
ROIC/WACC0.69
Cap/Depr(3y)161.65%
Cap/Depr(5y)133.06%
Cap/Sales(3y)6.75%
Cap/Sales(5y)5.95%
Profit Quality(3y)62.72%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-37.07%
EPS 3Y18.66%
EPS 5YN/A
EPS Q2Q%-48.54%
EPS Next Y-16.55%
EPS Next 2Y-3.92%
EPS Next 3Y0.36%
EPS Next 5Y0.42%
Revenue 1Y (TTM)-4.11%
Revenue growth 3Y4.72%
Revenue growth 5Y2.98%
Sales Q2Q%-0.86%
Revenue Next Year-2.46%
Revenue Next 2Y-2.11%
Revenue Next 3Y-0.62%
Revenue Next 5YN/A
EBIT growth 1Y-37.2%
EBIT growth 3Y-21.11%
EBIT growth 5Y2.83%
EBIT Next Year44.63%
EBIT Next 3Y16.29%
EBIT Next 5Y10.56%
FCF growth 1Y-89.2%
FCF growth 3Y-55.78%
FCF growth 5Y-31.76%
OCF growth 1Y-23.74%
OCF growth 3Y2.01%
OCF growth 5Y0.47%